RESUMEN
Säo analisados 8 pacientes submetidos a apendicectomia, durante o estadiamento cirúrgico da doença de Hodgkin (DH), dentre um total de 73 casos. Houve predomínio no sexo masculino. A indicaçäo de apendicectomia foi baseada na suspeita do cirurgiäo da presença de DH, palpando nódulo apendicular. O estudo histopatológico dos apêndices vermioformes ressecados apresentou ausência da DH. Quatro pacientes apresentaram estádio patológico III, com 2 complicaçöes pós-operatórias imediatas, ou seja, hemoperitônio e abscesso de parede. É sugerido que a apendicectomia só deva ser realizada quando existe suspeiçäo macroscópica de acometimento apendicular e nos tipos histológicos de pior prognóstico, recomendando-se que näo deva ser procedida rotineiramente no estadiamento cirúrgico da doença de Hodgkin
Asunto(s)
Humanos , Masculino , Femenino , Apendicectomía/estadística & datos numéricos , Enfermedad de Hodgkin/análisis , Brasil , Enfermedad de Hodgkin/diagnósticoRESUMEN
Beta 2 microglobulin is a low molecular weight protein integrating the light chain HLA antigens. Its serum concentration is increased in different neoplasias and in renal failure. Using solid phase RIA we determined the concentration of beta 2 microglobulin in plasma and spinal fluid of 57 healthy individuals and patients with hematologic neoplasia. Serum levels were 1.34 +/- 0.34 mg/l and spinal fluid levels were 1.3 +/- 0.7 mg/l in healthy subjects. Serum levels in 29 patients with myeloma was 7.51 mg/l, significantly higher in those with renal failure (12.35 mg/l) compared to those without (4.54). In 30 patients with non-Hodgkin lymphoma the mean serum levels were 2.90 mg/l, significantly greater in those with active disease (3.18) than in those with remission (1.5). No difference was found according to the degree of malignancy. Patients with acute lymphatic leukemia had elevated values of beta 2 microglobulin while the disease was active (3.37 mg/l), decreasing to normal levels after remission (1.79 mg/l). Spinal fluid levels of beta 2 microglobulin were elevated only in patients with central nervous system involvement. Our results indicate that serum levels of beta 2 microglobulin are helpful in patients with hematologic neoplasia in assessing the activity of the disease and tumor mass, especially in multiple myeloma.
Asunto(s)
Enfermedad de Hodgkin/análisis , Mieloma Múltiple/análisis , Leucemia-Linfoma Linfoblástico de Células Precursoras/líquido cefalorraquídeo , Microglobulina beta-2/análisis , Adolescente , Adulto , Anciano , Donantes de Sangre , Humanos , Persona de Mediana Edad , Valores de Referencia , Microglobulina beta-2/líquido cefalorraquídeoRESUMEN
Peanut agglutinin (PNA) binding glycoproteins from four Hodgkin's disease (HD)-derived cell lines and a variety of cell lines/peripheral blood cells representative of the lymphoid and myeloid lineages were identified by probing nitrocellulose membranes of SDS-PAGE separated NP40 solubilized cellular glycoproteins with [125I]-labelled PNA. The two Hodgkin's cell lines Ho and L428 demonstrated the most heterogeneous glycoprotein profiles each expressing 15 PNA binding glycoproteins, respectively. The two remaining Hodgkin's lines Co and L591 expressed only four glycoproteins each and these were all also commonly expressed by Ho and L428. Comparative analysis with all other cell types studied revealed the expression of five glycoproteins restricted to Ho (gp42, gp40, gp38, gp24 and gp22) and six restricted to L428 (gp180, gp75, gp40, gp38, gp24 and gp22). Four of these, gp40, gp38, gp24 and gp22 were commonly expressed by both Ho and L428. Of cell lines of myeloid lineage studied only the erythroleukemia cell line K562 expressed detectable glycoproteins also expressed by some of the Hodgkin's cell lines (gp110, gp96, gp50 and gp45). Only one glycoprotein, gp20 expressed by Ho was also commonly expressed by normal peripheral blood granulocytes. This limited study has thus succeeded in demonstrating for the range of cell types studied, that some glycoproteins with terminal D-galactose beta (1----3) N-acetyl galactosamine oligosaccharide sequences are apparently restricted to two of the HD cell lines. Moreover, the heterogeneous glycoprotein profiles obtained for the HD cell lines Ho and L428 suggests that galactosylation processes in these two cell lines is aberrant.
Asunto(s)
Arachis , Enfermedad de Hodgkin/análisis , Receptores Mitogénicos/análisis , Western Blotting , Línea Celular , Colodión , Glicoproteínas/aislamiento & purificación , Glicoproteínas/metabolismo , Enfermedad de Hodgkin/metabolismo , Humanos , Radioisótopos de Yodo , Peso Molecular , Proteínas de Neoplasias/aislamiento & purificación , Proteínas de Neoplasias/metabolismo , Papel , Fenotipo , Receptores Mitogénicos/aislamiento & purificación , Coloración y EtiquetadoRESUMEN
We have determined the tumor cell immunophenotype and the rearrangement configuration of immunoglobulin and T-cell receptor genes in 39 cases of Hodgkin's disease (HD), six HD-derived cell lines and 22 cases of Ki-1-positive anaplastic large cell lymphomas (Ki-1-ALC). Rearrangements were observed in 11/39 HD cases, 15/22 Ki-1-ALC, and all cell lines. Epstein-Barr virus DNA was found in five HD cases, one cell line, and one Ki-1-ALC. Both HD and Ki-1-ALC frequently displayed a dissociated genotypic and phenotypic maturation status, i.e. an immature genotype in association with late activation markers. We postulate that the tumor cells in many cases of HD and some cases of Ki-1-ALC may be derived from immature lymphoid cells by a transformation process that superimposes characteristics of mature activated lymphocytes on these cells.
Asunto(s)
Antígenos de Diferenciación , Antígenos de Neoplasias , Reordenamiento Génico de Linfocito T , Genes de Inmunoglobulinas , Enfermedad de Hodgkin/genética , Linfoma no Hodgkin/genética , Receptores de Antígenos de Linfocitos T/genética , Antígenos de Diferenciación/análisis , Antígenos de Neoplasias/análisis , Línea Celular , Diagnóstico Diferencial , Genotipo , Enfermedad de Hodgkin/análisis , Enfermedad de Hodgkin/patología , Humanos , Antígeno Ki-1 , Linfoma no Hodgkin/análisis , Linfoma no Hodgkin/patología , Fenotipo , Receptores de Antígenos de Linfocitos T/análisisRESUMEN
Eleven cases of thyroid lymphoma were studied by the immunoperoxidase avidin-biotin technique with calcitonin and somatostatin rabbit antisera. In 6 cases of non-Hodgkin lymphoma, in thyroid tissue residual to the lymphomatous infiltration, the C cell density was markedly increased and clustering was often observed; the C cells often took part in the follicular lining, frequently with polar distribution; these elements displayed a strong positivity for calcitonin, while the number of somatostatin-containing cells was lower and the staining less intense. In the only case of Hodgkin's lymphoma of the thyroid gland the staining was negative; in other 4 cases of non-Hodgkin lymphoma no residual thyroid tissue was found and the staining was also negative. As Hashimoto's thyroiditis is often associated with thyroid lymphoma, 13 cases of Hashimoto's thyroiditis were also studied; no C cells were observed and both stainings were negative. These data show that an increase in the C cell number may be a hallmark of thyroid lymphoma and that hyperplastic C cells show an intensive positivity for calcitonin. On the other hand, C cell hyperplasia is not present in Hashimoto's thyroiditis, in spite of the close association with thyroid lymphoma. Furthermore, we provide evidence that somatostatin-containing cells are present both in normal thyroid glands and in thyroid lymphoma.
Asunto(s)
Calcitonina/análisis , Linfoma/análisis , Somatostatina/análisis , Glándula Tiroides/análisis , Neoplasias de la Tiroides/análisis , Tiroiditis Autoinmune/patología , Enfermedad de Hodgkin/análisis , Enfermedad de Hodgkin/patología , Humanos , Hiperplasia , Inmunohistoquímica , Linfoma/patología , Linfoma no Hodgkin/análisis , Linfoma no Hodgkin/patología , Glándula Tiroides/citología , Glándula Tiroides/patología , Neoplasias de la Tiroides/patologíaRESUMEN
Monoclonal antibody Leu-22 (L60) detects a T cell-associated antigen which is stably expressed in routinely fixed and paraffin-embedded tissue sections. We investigated the utility of monoclonal antibody Leu-22 to immunophenotype routinely processed lymphoid neoplasms by determining its reactivity in 105 archival pathologic specimens of lymphoid neoplasia that had been previously immunophenotyped by standard cell suspension and frozen tissue section techniques. Monoclonal antibody Leu-22 reacted with 69% of T cell non-Hodgkin's lymphomas (NHLs), including cases belonging to each of the major clinicopathologic categories, and with 22% of B cell NHLs, but did not react with the Reed-Sternberg (RS) cells of Hodgkin's disease (HD). We concluded that monoclonal antibody Leu-22 reacts preferentially but not exclusively with T cell NHLs. Therefore, we performed parallel analyses of the same 105 cases with monoclonal antibodies leukocyte common antigen (LCA), Leu-M1, LN1, and LN2, which detect various paraffin-resistant antigens, and of 80 of these cases with monoclonal antibody UCHL1, which detects a paraffin-resistant T cell-associated antigen. UCHL1 reacted with 61% of the T cell NHLs studied. Sixty-nine percent of T cell NHLs expressed the LCA+, Leu-22+ or Leu-M1+, LN1- phenotype and 47% of B cell NHLs expressed the LCA+, Leu-22-, Leu-M1-, LN1+ phenotype. These phenotypes had a false-positive rate of only 7%. The substitution of UCHL1 for Leu-22 or the combined use of UCHL1 and Leu-22 in this panel did not improve our ability to correctly predict the T cell phenotype of these lymphoid neoplasms. LN1 and LN2 reacted with 13% and 56% of T cell NHLs, respectively, and LN2 reacted with RS cells in 85% of cases of HD. In summary, our results demonstrate that the judicious use of monoclonal antibody Leu-22 in combination with other selected commercially available monoclonal antibodies permits the determination of the B cell or T cell origin of a high proportion of NHLs, and is helpful in the differential diagnosis between HD and NHL among cases that have been routinely fixed and paraffin-embedded.
Asunto(s)
Linfocitos B , Enfermedad de Hodgkin/patología , Linfoma no Hodgkin/patología , Linfocitos T , Anticuerpos Monoclonales , Antígenos de Diferenciación/análisis , Linfocitos B/análisis , Diagnóstico Diferencial , Antígenos de Histocompatibilidad/análisis , Enfermedad de Hodgkin/análisis , Humanos , Técnicas para Inmunoenzimas , Antígenos Comunes de Leucocito , Linfoma no Hodgkin/análisis , Glicoproteínas de Membrana/análisis , Linfocitos T/análisisRESUMEN
The HeFi-1 mAb recognizes a membrane protein on Hodgkin's disease cells and on a limited number of other human cells that are either tumorigenically transformed or virally activated. Herein biochemical and structural analyses of the HeFi-1 reactive membrane protein (HRMP) were done to identify its potential importance in cellular transformation in the Hodgkin's disease cell line L428, in the T cell lymphoma line HuT 78, and in several EBV-transformed lymphoblastoid cell lines. Immunoprecipitation studies demonstrated that the mature form of the HRMP had an apparent Mr of 120 kDa in tumor cells and 116 kDa in the EBV-transformed cell lines and that it was phosphorylated at both serine and tyrosine residues in all cell lines tested. The precursor to the HRMP is an 86-kDa core protein that, after processing by high mannose N-linked glycosylation, migrates with an apparent Mr of 90 kDa. This protein is then further processed to the mature 120-kDa HRMP in part by O-linked glycosylation, the addition of sialic acid residues, and by the conversion of N-linked oligosaccharides from the high mannose to the complex type. Detectable amounts of the 90-kDa molecule can be found in the membrane and, although this protein can be phosphorylated in vitro, it is not phosphorylated in intact cells. The combined results of this study suggest that the HRMP is involved in cellular metabolism and show that an unusual amount of post-translational processing of the 90-kDa precursor results in the formation, and perhaps phosphorylation, of the mature 120-kDa HRMP.
Asunto(s)
Anticuerpos Monoclonales , Enfermedad de Hodgkin/análisis , Proteínas de la Membrana/aislamiento & purificación , Proteínas de Neoplasias/aislamiento & purificación , Aminoácidos/metabolismo , Reacciones Antígeno-Anticuerpo , Línea Celular , Enfermedad de Hodgkin/inmunología , Enfermedad de Hodgkin/metabolismo , Humanos , Proteínas de la Membrana/inmunología , Proteínas de la Membrana/metabolismo , Peso Molecular , Proteínas de Neoplasias/inmunología , Proteínas de Neoplasias/metabolismo , Fosfoproteínas/metabolismo , Fosforilación , Procesamiento Proteico-PostraduccionalRESUMEN
Flow cytometry was performed on paraffin embedded tissue from 115 cases of Hodgkin's disease. Thirteen (11%) tumours were aneuploid with no significant difference between the histological subgroups. The median proliferative index was 14%, and the highest values were found in the NS2 (16.4%) and lymphocyte depleted (16.0%) subgroups. The difference in proliferative index approached significance when the NS2 subgroup was compared with the NS1 subgroup (p less than or equal to 0.11) and when the lymphocyte depleted and NS2 subgroups combined were compared with the mixed cellularity, lymphocyte predominance, and NS1 subgroups combined (p less than or equal to 0.07). There was a trend towards better survival for patients with aneuploid tumours and those cases with a proliferative index below 15%, but neither of these trends was significant.
Asunto(s)
ADN de Neoplasias/análisis , Enfermedad de Hodgkin/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Citometría de Flujo , Enfermedad de Hodgkin/análisis , Enfermedad de Hodgkin/mortalidad , Humanos , Lactante , Masculino , Persona de Mediana Edad , Mitosis , PronósticoRESUMEN
The typical tissue isoferritin pattern varies during neoplastic transformation, usually shifting toward a more acidic profile. To investigate the molecular basis of this phenomenon, we have analyzed the steady-state levels of the H and L mRNAs in several neoplastic tissues. By using specific probes for the two ferritin subunits, we have found, in three different adenocarcinomas and in a case of Hodgkin lymphoma, a two- to four-fold increase of the H and L mRNA levels compared to those found in normal human liver.
Asunto(s)
Ferritinas/genética , Neoplasias/análisis , ARN Mensajero/análisis , Adenocarcinoma/análisis , Neoplasias del Colon/análisis , Enfermedad de Hodgkin/análisis , Humanos , Técnicas In Vitro , Neoplasias Hepáticas/análisis , Neoplasias Gástricas/análisisAsunto(s)
ADN de Neoplasias/análisis , Linfoma/análisis , Adolescente , Adulto , Anciano , Biopsia con Aguja/métodos , Núcleo Celular/análisis , Femenino , Enfermedad de Hodgkin/análisis , Enfermedad de Hodgkin/patología , Humanos , Linfoma/patología , Linfoma no Hodgkin/análisis , Linfoma no Hodgkin/patología , Masculino , Persona de Mediana Edad , Espectrofotometría/métodosRESUMEN
A case is reported of nodular lymphocyte predominant Hodgkin's disease arising 13 years after the removal of a lymph node from the same site which showed marked progressive transformation of germinal centres. The morphological evidence for a histogenetic relationship between the two conditions is presented and discussed.
Asunto(s)
Transformación Celular Neoplásica/patología , Enfermedad de Hodgkin/patología , Adulto , Células Dendríticas/ultraestructura , Antígenos de Histocompatibilidad/análisis , Enfermedad de Hodgkin/análisis , Enfermedad de Hodgkin/inmunología , Humanos , Técnicas para Inmunoenzimas , Antígenos Comunes de Leucocito , Ganglios Linfáticos/patología , Masculino , Linfocitos T/inmunología , Linfocitos T/ultraestructuraRESUMEN
The nature of Hodgkin and Reed-Sternberg (H-RS) cells and their normal counterpart remains a matter of controversy. Our recent investigations have suggested that H-RS-cells derive from certain activated lymphocytes of either B or T cell origin. In keeping with this concept, we were able to demonstrate that in the majority of cases of Hodgkin's disease the interleukin-2 receptor (IL2-R) was detectable on H-RS-cells by three monoclonal antibodies (anti-Tac, Tü69 and ACT-1) with the sensitive alkaline phosphatase anti-alkaline phosphatase (APAAP) tissue staining procedure. In extension of these studies, we precipitated IL2-R antigen from two established permanent cell lines (L540 and L591) derived from patients with Hodgkin's disease. Although these cell lines are different in nature, in that the L540 line shows rearrangement for the T cell receptor beta chain gene and the L591 line displays rearrangement for immunoglobulin genes (gamma heavy and lambda light chain), the antigen precipitated by monoclonal antibodies against IL2-R exhibited a molecular weight of approximately 53 kd on the L591 line and 58 kd on the L540 line. Thus, these data strongly support the view that the labelling of H-RS-cells in tissue sections for IL2-R was not merely due to cross-reactivities of the two anti-IL2-R antibodies with a determinant of an unrelated structure but represents true IL2-R molecules.
Asunto(s)
Anticuerpos Monoclonales , Enfermedad de Hodgkin/patología , Receptores Inmunológicos/análisis , Línea Celular , Enfermedad de Hodgkin/análisis , Humanos , Técnicas para Inmunoenzimas , Técnicas In Vitro , Receptores de Interleucina-2RESUMEN
A group of monoclonal antibodies was shown to react with glycoconjugates containing a sugar sequence--lacto-N-fucopentaose III (LNF-III)--in granulocytes and in some normal nonlymphoid cells. The antibodies including anti-Leu M1, anti-My-1, WGHS 29-1, 534F-8, and 538F-12 of the immunoglobulin M-type were used to study the biochemical properties of LNF-III antigens in granulocytes, interdigitating reticulum cells, and neoplastic cells of Hodgkin's disease. In contrast to the presence of an abundant LNF-III glycolipid in granulocytes, the Hodgkin's neoplastic cells had no LNF-III glycolipid or contained only minimal amounts; however, both LNF-III glycoconjugates isolated from Hodgkin's neoplastic cells and interdigitating reticulum cells appeared to be a similar, if not an identical, 150,000-molecular-weight glycoprotein. The neoplastic cells in Hodgkin's disease appeared to show a biochemical property more closely related to interdigitating reticulum cells than any other cells in the monocyte-granulocyte-histiocyte system.
Asunto(s)
Antígenos de Superficie/análisis , Granulocitos/análisis , Histiocitos/análisis , Enfermedad de Hodgkin/patología , Anticuerpos Monoclonales , Antígenos de Diferenciación de Linfocitos T , Autorradiografía , Electroforesis en Gel de Poliacrilamida , Glucolípidos/análisis , Histocitoquímica , Enfermedad de Hodgkin/análisis , Humanos , RadioinmunoensayoRESUMEN
The distribution of iron and iron binding proteins (IBP) have been compared with control spleen tissue in an attempt to establish a pattern of staining restricted to Hodgkin's disease (HD). All but one of the HD spleens examined stained for ferritin, which was largely present in red pulp dendritic macrophages (DM). In spleens histologically involved with HD heavy deposits of ferritin were seen around tumour nodules. Staining for ferritin increased with involvement of the spleen in HD but DM still represented the bulk of positive cells. However, ferritin positive DM were frequently seen in control spleens, and often in large numbers. Staining of ferric iron by Perls technique was less prominent than ferritin but this observation was also true of the non-HD spleens studied. Patterns of staining with transferrin were equivalent in both groups of spleens with DM being the most frequently positive cell type. Polymorphous macrophages showing erythrophagocytosis were present in the red pulp sinuses of all groups of spleens and although these cells have been considered as precursors of the Reed-Sternberg cell their presence seemed related to total splenic ferritin regardless of the disease process. These cells marked as macrophages and their presence was not restricted to HD. The results show that there is no particular appearance of iron or IBP distribution which is restricted to HD spleens. However, staining for ferritin and iron increased in HD spleens with tumour involvement and could contribute to circulatory abnormalities in this disease.
Asunto(s)
Ferritinas/análisis , Enfermedad de Hodgkin/análisis , Hierro/análisis , Bazo/análisis , Transferrina/análisis , Humanos , Lactoferrina/análisis , Linfoma/análisis , Macrófagos/análisis , Talasemia/metabolismoRESUMEN
Several studies have shown that the Leu-M1 antigen, a monocyte/granulocyte-related marker, is consistently expressed by the neoplastic cells of patients with Hodgkin's disease (HD). It has been suggested that reactivity of Reed-Sternberg cells with Leu-M1 can be used in support of a morphologic interpretation of HD, and that it is helpful in the differential diagnosis of HD from morphologically similar lesions. To evaluate the significance of the Leu-M1 positivity of Reed-Sternberg cells in the diagnosis of HD, we investigated the distribution of Leu-M1 antigen in a series of patients with HD, non-Hodgkin's lymphomas, and nonhematopoietic neoplasms. We were able to demonstrate the presence of Leu-M1 antigen not only in the majority of patients with HD, but also in 12 of 18 (67%) peripheral T-cell lymphomas, as well as in a variety of nonhematopoietic neoplasms, which included 113 of 199 carcinomas, most of them (58%) adenocarcinomas. Only one of 34 sarcomas showed a focal positive reaction. Leu-M1-related antigen was not detected in any of 18 mesotheliomas, 15 germ cell tumors, 13 melanomas, three schwannomas, or three astrocytomas. Our study indicates that Leu-M1 positivity has no value in supporting the diagnosis of HD in situations where the histologic diagnosis of HD is doubtful. However, since anti-Leu-M1 reacted positively in the majority of adenocarcinomas but was absent in mesotheliomas, melanomas, and most sarcomas, this antigen could serve as a new marker that may be helpful in situations in which carcinoma is a part of the differential diagnosis.
Asunto(s)
Antígenos de Superficie/análisis , Neoplasias/inmunología , Adenocarcinoma/análisis , Antígenos de Diferenciación de Linfocitos T , Neoplasias de la Mama/análisis , Histocitoquímica , Enfermedad de Hodgkin/análisis , Humanos , Técnicas Inmunológicas , Ganglios Linfáticos/patología , Mesotelioma/análisis , Neoplasias/análisis , Timoma/análisis , Neoplasias del Timo/análisisRESUMEN
Seven patients with Hodgkin's disease were studied for the presence of lysozyme and alpha-1-antitrypsin activity by immunoelectron microscopy. As a result, Reed-Sternberg cells, Hodgkin's cells, and atypical cells were distinctly positive for lysozyme in four cases and weakly positive in the remaining three cases. These cells were also positive for alpha-1-antitrypsin in all cases. Because the cells of the monocyte-macrophage lineage also bore lysozyme and alpha-1-antitrypsin, it is suggested that Reed-Sternberg cells, Hodgkin's cells, and the atypical cells are derived from the monocyte-macrophage lineage.